M. Araz Et Al. , "Negative Histopathological Prognostic Factors Affecting Morbidity in T1 Differentiated Thyroid Carcinoma," CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS , vol.37, pp.56-62, 2022
Araz, M. Et Al. 2022. Negative Histopathological Prognostic Factors Affecting Morbidity in T1 Differentiated Thyroid Carcinoma. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS , vol.37 , 56-62.
Araz, M., Özkan, E., Gündüz, P., Soydal, Ç., Küçük, N. Ö., & Kır, K. M., (2022). Negative Histopathological Prognostic Factors Affecting Morbidity in T1 Differentiated Thyroid Carcinoma. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS , vol.37, 56-62.
Araz, MİNE Et Al. "Negative Histopathological Prognostic Factors Affecting Morbidity in T1 Differentiated Thyroid Carcinoma," CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS , vol.37, 56-62, 2022
Araz, MİNE Et Al. "Negative Histopathological Prognostic Factors Affecting Morbidity in T1 Differentiated Thyroid Carcinoma." CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS , vol.37, pp.56-62, 2022
Araz, M. Et Al. (2022) . "Negative Histopathological Prognostic Factors Affecting Morbidity in T1 Differentiated Thyroid Carcinoma." CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS , vol.37, pp.56-62.
@article{article, author={MİNE ARAZ Et Al. }, title={Negative Histopathological Prognostic Factors Affecting Morbidity in T1 Differentiated Thyroid Carcinoma}, journal={CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS}, year=2022, pages={56-62} }